Verapamil inhibits efflux pumps in Candida albicans, exhibits synergism with fluconazole, and increases survival of Galleria mellonella

Detalhes bibliográficos
Autor(a) principal: Vega-Chacón, Yuliana [UNESP]
Data de Publicação: 2021
Outros Autores: de Albuquerque, Maria Carolina [UNESP], Pavarina, Ana Cláudia [UNESP], Goldman, Gustavo Henrique, Mima, Ewerton Garcia de Oliveira [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1080/21505594.2020.1868814
http://hdl.handle.net/11449/208309
Resumo: The emergence of resistance requires alternative methods to treat Candida albicans infections. We evaluated efficacy of the efflux pump inhibitor (EPI) verapamil (VER) with fluconazole (FLC) against FLC-resistant (CaR) and -susceptible C. albicans (CaS). The susceptibility of both strains to VER and FLC was determined, as well as the synergism of VER with FLC. Experiments were performed in vitro for planktonic cultures and biofilms and in vivo using Galleria mellonella. Larval survival and fungal recovery were evaluated after treatment with VER and FLC. Data were analyzed by analysis of variance and Kaplan-Meier tests. The combination of VER with FLC at sub-lethal concentrations reduced fungal growth. VER inhibited the efflux of rhodamine 123 and showed synergism with FLC against CaR. For biofilms, FLC and VER alone reduced fungal viability. The combination of VER with FLC at sub-lethal concentrations also reduced biofilm viability. In the in vivo assays, VER and FLC used alone or in combination increased the survival of larvae infected with CaR. Reduction of fungal recovery was observed only for larvae infected with CaR and treated with VER with FLC. VER reverted the FLC-resistance of C. albicans. Based on the results obtained, VER reverted the FLC-resistance of C. albicans and showed synergism with FLC against CaR. VER also increased the survival of G. mellonella infected with CaR and reduced the fungal recovery.
id UNSP_2f55a1a1f4b094310b1d0260b560e7ab
oai_identifier_str oai:repositorio.unesp.br:11449/208309
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Verapamil inhibits efflux pumps in Candida albicans, exhibits synergism with fluconazole, and increases survival of Galleria mellonellaCandida albicansdrug resistanceGalleria mellonellamembrane transport proteinsvirulenceThe emergence of resistance requires alternative methods to treat Candida albicans infections. We evaluated efficacy of the efflux pump inhibitor (EPI) verapamil (VER) with fluconazole (FLC) against FLC-resistant (CaR) and -susceptible C. albicans (CaS). The susceptibility of both strains to VER and FLC was determined, as well as the synergism of VER with FLC. Experiments were performed in vitro for planktonic cultures and biofilms and in vivo using Galleria mellonella. Larval survival and fungal recovery were evaluated after treatment with VER and FLC. Data were analyzed by analysis of variance and Kaplan-Meier tests. The combination of VER with FLC at sub-lethal concentrations reduced fungal growth. VER inhibited the efflux of rhodamine 123 and showed synergism with FLC against CaR. For biofilms, FLC and VER alone reduced fungal viability. The combination of VER with FLC at sub-lethal concentrations also reduced biofilm viability. In the in vivo assays, VER and FLC used alone or in combination increased the survival of larvae infected with CaR. Reduction of fungal recovery was observed only for larvae infected with CaR and treated with VER with FLC. VER reverted the FLC-resistance of C. albicans. Based on the results obtained, VER reverted the FLC-resistance of C. albicans and showed synergism with FLC against CaR. VER also increased the survival of G. mellonella infected with CaR and reduced the fungal recovery.Laboratory of Applied Microbiology Department of Dental Materials and Prosthodontics São Paulo State University (UNESP) School of DentistryFaculdade de Ciências Farmacêuticas de Ribeirão Preto Universidade de São Paulo (USP)Laboratory of Applied Microbiology Department of Dental Materials and Prosthodontics São Paulo State University (UNESP) School of DentistryUniversidade Estadual Paulista (Unesp)Universidade de São Paulo (USP)Vega-Chacón, Yuliana [UNESP]de Albuquerque, Maria Carolina [UNESP]Pavarina, Ana Cláudia [UNESP]Goldman, Gustavo HenriqueMima, Ewerton Garcia de Oliveira [UNESP]2021-06-25T11:10:06Z2021-06-25T11:10:06Z2021-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article231-243http://dx.doi.org/10.1080/21505594.2020.1868814Virulence, v. 12, n. 1, p. 231-243, 2021.2150-56082150-5594http://hdl.handle.net/11449/20830910.1080/21505594.2020.18688142-s2.0-85099175905Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengVirulenceinfo:eu-repo/semantics/openAccess2021-10-23T19:01:58Zoai:repositorio.unesp.br:11449/208309Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462021-10-23T19:01:58Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Verapamil inhibits efflux pumps in Candida albicans, exhibits synergism with fluconazole, and increases survival of Galleria mellonella
title Verapamil inhibits efflux pumps in Candida albicans, exhibits synergism with fluconazole, and increases survival of Galleria mellonella
spellingShingle Verapamil inhibits efflux pumps in Candida albicans, exhibits synergism with fluconazole, and increases survival of Galleria mellonella
Vega-Chacón, Yuliana [UNESP]
Candida albicans
drug resistance
Galleria mellonella
membrane transport proteins
virulence
title_short Verapamil inhibits efflux pumps in Candida albicans, exhibits synergism with fluconazole, and increases survival of Galleria mellonella
title_full Verapamil inhibits efflux pumps in Candida albicans, exhibits synergism with fluconazole, and increases survival of Galleria mellonella
title_fullStr Verapamil inhibits efflux pumps in Candida albicans, exhibits synergism with fluconazole, and increases survival of Galleria mellonella
title_full_unstemmed Verapamil inhibits efflux pumps in Candida albicans, exhibits synergism with fluconazole, and increases survival of Galleria mellonella
title_sort Verapamil inhibits efflux pumps in Candida albicans, exhibits synergism with fluconazole, and increases survival of Galleria mellonella
author Vega-Chacón, Yuliana [UNESP]
author_facet Vega-Chacón, Yuliana [UNESP]
de Albuquerque, Maria Carolina [UNESP]
Pavarina, Ana Cláudia [UNESP]
Goldman, Gustavo Henrique
Mima, Ewerton Garcia de Oliveira [UNESP]
author_role author
author2 de Albuquerque, Maria Carolina [UNESP]
Pavarina, Ana Cláudia [UNESP]
Goldman, Gustavo Henrique
Mima, Ewerton Garcia de Oliveira [UNESP]
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv Vega-Chacón, Yuliana [UNESP]
de Albuquerque, Maria Carolina [UNESP]
Pavarina, Ana Cláudia [UNESP]
Goldman, Gustavo Henrique
Mima, Ewerton Garcia de Oliveira [UNESP]
dc.subject.por.fl_str_mv Candida albicans
drug resistance
Galleria mellonella
membrane transport proteins
virulence
topic Candida albicans
drug resistance
Galleria mellonella
membrane transport proteins
virulence
description The emergence of resistance requires alternative methods to treat Candida albicans infections. We evaluated efficacy of the efflux pump inhibitor (EPI) verapamil (VER) with fluconazole (FLC) against FLC-resistant (CaR) and -susceptible C. albicans (CaS). The susceptibility of both strains to VER and FLC was determined, as well as the synergism of VER with FLC. Experiments were performed in vitro for planktonic cultures and biofilms and in vivo using Galleria mellonella. Larval survival and fungal recovery were evaluated after treatment with VER and FLC. Data were analyzed by analysis of variance and Kaplan-Meier tests. The combination of VER with FLC at sub-lethal concentrations reduced fungal growth. VER inhibited the efflux of rhodamine 123 and showed synergism with FLC against CaR. For biofilms, FLC and VER alone reduced fungal viability. The combination of VER with FLC at sub-lethal concentrations also reduced biofilm viability. In the in vivo assays, VER and FLC used alone or in combination increased the survival of larvae infected with CaR. Reduction of fungal recovery was observed only for larvae infected with CaR and treated with VER with FLC. VER reverted the FLC-resistance of C. albicans. Based on the results obtained, VER reverted the FLC-resistance of C. albicans and showed synergism with FLC against CaR. VER also increased the survival of G. mellonella infected with CaR and reduced the fungal recovery.
publishDate 2021
dc.date.none.fl_str_mv 2021-06-25T11:10:06Z
2021-06-25T11:10:06Z
2021-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1080/21505594.2020.1868814
Virulence, v. 12, n. 1, p. 231-243, 2021.
2150-5608
2150-5594
http://hdl.handle.net/11449/208309
10.1080/21505594.2020.1868814
2-s2.0-85099175905
url http://dx.doi.org/10.1080/21505594.2020.1868814
http://hdl.handle.net/11449/208309
identifier_str_mv Virulence, v. 12, n. 1, p. 231-243, 2021.
2150-5608
2150-5594
10.1080/21505594.2020.1868814
2-s2.0-85099175905
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Virulence
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 231-243
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1792961806238482432